Clinical trials launch
Clinical trials starts in Bellvitge Hospital for new area of care of our medical device. Proof-of-concept phase launched for peritoneal dialysis-related peritonitis in Bellvitge University Hospital (Barcelona, Spain).
Scientific Impact at ESPID
Proof-of-concept study abstract presentation at the 41st Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID). Preliminary results for infant meningitis were extremely well received in this prestigious medical congress.
Clinical trial extension to Morroco
Extension to Rabat (Morroco) for the efficacy phase of the clinical trial for infant meningitis.Quoting the words of our clinical lead Dr. Quique Bassat, this a giant step forward that will undoubtedly contribute to reducing the huge mismatch between the burden of infectious diseases and the few research resources dedicated to them in the country.
Scientific Impact at MRF Conference 2021
2021 MRF Conference poster presentation by Dr. Quique Bassat, clinical lead, epidemiologist and meningitis expert.He shared the study coordinated by the Barcelona Institute of Global Health (ISGlobal) and implemented at Maputo Central Hospital, Mozambique.
Clinical trials launch in Spain and Mozambique
Proof of Concept launch of the clinical trials for infant meningitis, with our non-invasive white blood cell counter for newborns and infants with an open fontanelle. Multisite study with the prestigious Hospital Universitario La Paz (Madrid), Hospital Universitario Quirón Madrid (Pozuelo de Alarcón) and ISGlobal Barcelona at Centro de Investigaçao em Saúde de Manhiça -CISM (Mozambique).
